Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease but the second cause of death among NAFLD patients are attributed to malignancies at both gastrointestinal (liver, colon, esophagus, stomach, and pancreas) and extra-intestinal sites (kidney in men, and breast in w...
Main Authors: | Claudia Sanna, Chiara Rosso, Milena Marietti, Elisabetta Bugianesi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/5/717 |
Similar Items
-
Gut microbiota and nonalcoholic fatty liver disease
by: XIAO Li, et al.
Published: (2017-04-01) -
Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function
by: Ji Taek Hong, et al.
Published: (2021-03-01) -
Boom of probiotics: This time non-alcoholic fatty liver disease – A mini review
by: Shayan Mohammadmoradi, et al.
Published: (2014-11-01) -
Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota
by: Huilin Liu, et al.
Published: (2018-09-01) -
Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression
by: Youlian Zhou, et al.
Published: (2018-12-01)